ELOXX PHARMACEUTICALS, INC. Conversion of Stock, Shares Converted
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Conversion of Stock, Shares Converted of 10.00 thousand shares for the 6-month period ending 2016-12-31, per its 10-Q filed 2017-02-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2017-02-10
- 2016-12-31: Conversion of Stock, Shares Converted 6 month 10.00K shares.
| Period end | Conversion of Stock, Shares Converted 6 month |
|---|---|
| 2016-12-31 | 10.00K shares 10-Q · filed 2017-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |